Properties |
Information |
PhytoCAT-ID |
PhytoCAT-568 |
Phytochemical name or plant extracts |
Tricetin |
PMID |
19705844 |
Literature evidence |
These findings suggest that tricetin may be a promising chemopreventive agent against human breast cancer. |
IUPAC name |
5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one |
Phytochemicals’ class or type of plant extracts |
Flavonoid |
Source of phytochemicals or plant Extracts |
Punica granatum |
|
Geographical availability |
Afghanistan, Iran, Iraq, North Caucasus, Pakistan, Tadzhikistan, Transcaucasus, Turkey, Turkmenistan |
Plant parts |
NA |
Other cancers |
Breast cancer |
Target gene or protein |
Bax, Bak, p21, cdc2, cdc25C, Cyclin B, Bcl-2, Bcl-xL, ABCG2 |
Gene or Protein evidence |
Tricetin can inhibit cell cycle progression at the G2/M phase by increasing p21 expression in a p53-dependent manner, and by decreasing the expression of cdc2, cdc25C, and cyclin B. tricetin treatment resulted in a significant increase of Bax and Bak expression, and a decrease of Bcl-2 and Bcl-XL, suggesting that changes in the ratio of the proapoptotic and antiapoptotic Bcl-2 family proteins might contribute to the apoptosis-promotion activity of tricetin.
Chrysoeriol, laricitrin, myricetin 3',4',5'-trimethylether, pinocembrin, quercitrin, tamarixetin, tricetin and tricetin 3',4',5'-trimethylether were also identified as novel flavonoid ABCG2 inhibitors. |
Target pathways |
NA |
IC50 |
32.17 μM against MCF-7 cells |
Potency |
These findings suggest that tricetin may be a promising chemopreventive agent against human breast cancer. |
Cell line/ mice model |
MCF-7 |
Additional information |
In addition, pretreatment of cells with caspase-9 inhibitor blocked tricetin-induced apoptosis, indicating that caspase-9 activation is involved in tricetin-mediated MCF-7 cell apoptosis. |
PubChem ID |
5281701 |
Additional PMIDs |
23497885 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:554129-1 |
Safety |
NA |